Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Hans, Crezee"'
Autor:
Akke Bakker, Remko Zweije, H. Petra Kok, Lukas J. A. Stalpers, G. Henrike Westerveld, Karel A. Hinnen, Geertjan van Tienhoven, M. Willemijn Kolff, Hans Crezee
Publikováno v:
International Journal of Hyperthermia, Vol 39, Iss 1, Pp 1408-1414 (2022)
Objective The in-house developed 70 MHz AMC-4 locoregional hyperthermia system has been in clinical use since 1984. This device was recently commercialized as the Alba 4D (Medlogix®, Rome, Italy), with a similar geometrical 4-waveguide design. At th
Externí odkaz:
https://doaj.org/article/73ea93929dad46a2a642a3e68544d0bd
Autor:
H. Petra Kok, Marcus Beck, Daan R. Löke, Roxan F. C. P. A. Helderman, Geertjan van Tienhoven, Pirus Ghadjar, Peter Wust, Hans Crezee
Publikováno v:
International Journal of Hyperthermia, Vol 37, Iss 1, Pp 76-88 (2020)
Introduction Intravenous chemotherapy plus abdominal locoregional hyperthermia is explored as a noninvasive alternative to hyperthermic intraperitoneal chemotherapy (HIPEC) in treatment of peritoneal carcinomatosis (PC). First clinical results demons
Externí odkaz:
https://doaj.org/article/d51c9120152f4cc3a173afdbf35a6f38
Autor:
Soraya Gavazzi, Astrid L. H. M. W. van Lier, Cornel Zachiu, Eric Jansen, Jan J. W Lagendijk, Lukas J. A Stalpers, Hans Crezee, H. Petra Kok
Publikováno v:
International Journal of Hyperthermia, Vol 37, Iss 1, Pp 992-1007 (2020)
Hyperthermia treatment planning (HTP) is valuable to optimize tumor heating during thermal therapy delivery. Yet, clinical hyperthermia treatment plans lack quantitative accuracy due to uncertainties in tissue properties and modeling, and report tumo
Externí odkaz:
https://doaj.org/article/27fad9a0dc95494baa892fddfaf27b1d
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Moderate hyperthermia at temperatures between 40 and 44°C is a multifaceted therapeutic modality. It is a potent radiosensitizer, interacts favorably with a host of chemotherapeutic agents, and, in combination with radiotherapy, enforces immunomodul
Externí odkaz:
https://doaj.org/article/e3054e43336343dda0f0f1f8cb7dd5c9
Autor:
Akke Bakker, Jacoba van der Zee, Geertjan van Tienhoven, H. Petra Kok, Coen R. N. Rasch, Hans Crezee
Publikováno v:
International Journal of Hyperthermia, Vol 36, Iss 1, Pp 1023-1038 (2019)
Objective: Hyperthermia therapy (HT), heating tumors to 40–45 °C, is a known radiotherapy (RT) and chemotherapy sensitizer. The additional benefit of HT to RT for recurrent breast cancer has been proven in multiple randomized trials. However, publ
Externí odkaz:
https://doaj.org/article/e0d5c3be630c4eb5b0062b2e972c9ded
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Externí odkaz:
https://doaj.org/article/64139ac0c09c4bd2ad52ba8917e4aef5
Autor:
Akke Bakker, C. Paola Tello Valverde, Geertjan van Tienhoven, M. Willemijn Kolff, H. Petra Kok, Ben J. Slotman, Inge R.H.M. Konings, Arlene L. Oei, Hester S.A. Oldenburg, Emiel J.T. Rutgers, Coen R.N. Rasch, H.J.G. Desirée van den Bongard, Hans Crezee
Publikováno v:
Bakker, A, Tello Valverde, C P, van Tienhoven, G, Kolff, M W, Kok, H P, Slotman, B J, Konings, I R H M, Oei, A L, Oldenburg, H S A, Rutgers, E J T, Rasch, C R N, van den Bongard, H J G D & Crezee, H 2022, ' Post-operative re-irradiation with hyperthermia in locoregional breast cancer recurrence : Temperature matters ', Radiotherapy and Oncology, vol. 167, pp. 149-157 . https://doi.org/10.1016/j.radonc.2021.12.036
Radiotherapy & Oncology, 167, 149-157. ELSEVIER IRELAND LTD
Radiotherapy and oncology, 167(149-157), 149-157. Elsevier Ireland Ltd
Radiotherapy and Oncology, 167, 149-157. Elsevier Ireland Ltd
Radiotherapy & Oncology, 167, 149-157. ELSEVIER IRELAND LTD
Radiotherapy and oncology, 167(149-157), 149-157. Elsevier Ireland Ltd
Radiotherapy and Oncology, 167, 149-157. Elsevier Ireland Ltd
Purpose: To investigate the impact of hyperthermia thermal dose (TD) on locoregional control (LRC), overall survival (OS) and toxicity in locoregional recurrent breast cancer patients treated with postoperative re-irradiation and hyperthermia.Methods
Autor:
Mohammed Khurshed, Elia Prades-Sagarra, Sarah Saleh, Peter Sminia, Johanna W. Wilmink, Remco J. Molenaar, Hans Crezee, Cornelis J. F. van Noorden
Publikováno v:
Cancers, 14(24):6228. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers; Volume 14; Issue 24; Pages: 6228
Khurshed, M, Prades-Sagarra, E, Saleh, S, Sminia, P, Wilmink, J W, Molenaar, R J, Crezee, H & van Noorden, C J F 2022, ' Hyperthermia as a Potential Cornerstone of Effective Multimodality Treatment with Radiotherapy, Cisplatin and PARP Inhibitor in IDH1-Mutated Cancer Cells ', Cancers, vol. 14, no. 24, 6228 . https://doi.org/10.3390/cancers14246228
Cancers; Volume 14; Issue 24; Pages: 6228
Khurshed, M, Prades-Sagarra, E, Saleh, S, Sminia, P, Wilmink, J W, Molenaar, R J, Crezee, H & van Noorden, C J F 2022, ' Hyperthermia as a Potential Cornerstone of Effective Multimodality Treatment with Radiotherapy, Cisplatin and PARP Inhibitor in IDH1-Mutated Cancer Cells ', Cancers, vol. 14, no. 24, 6228 . https://doi.org/10.3390/cancers14246228
Mutations in the isocitrate dehydrogenase 1 (IDH1MUT) gene occur in various types of malignancies, including ~60% of chondrosarcomas, ~30% of intrahepatic cholangiocarcinomas and >80% of low-grade gliomas. IDH1MUT are causal in the development and pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e35fadd1195caa50a33d5fe32f89382
https://pure.amc.nl/en/publications/hyperthermia-as-a-potential-cornerstone-of-effective-multimodality-treatment-with-radiotherapy-cisplatin-and-parp-inhibitor-in-idh1mutated-cancer-cells(1b6df298-0130-4c36-9784-c15255383cfb).html
https://pure.amc.nl/en/publications/hyperthermia-as-a-potential-cornerstone-of-effective-multimodality-treatment-with-radiotherapy-cisplatin-and-parp-inhibitor-in-idh1mutated-cancer-cells(1b6df298-0130-4c36-9784-c15255383cfb).html
Autor:
Sebastiano Barbieri, Hans Crezee, Hanneke W. M. van Laarhoven, Misha P. T. Kaandorp, Peter T. While, Remy Klaassen, Aart J. Nederveen, Oliver J. Gurney-Champion
Publikováno v:
Magnetic Resonance in Medicine
Magnetic resonance in medicine, 86(4), 2250-2265. John Wiley and Sons Inc.
Magnetic resonance in medicine, 86(4), 2250-2265. John Wiley and Sons Inc.
Purpose: Earlier work showed that IVIM-NET orig, an unsupervised physics-informed deep neural network, was faster and more accurate than other state-of-the-art intravoxel-incoherent motion (IVIM) fitting approaches to diffusion-weighted imaging (DWI)
Autor:
Tim Ottens, Sebastiano Barbieri, Matthew R. Orton, Remy Klaassen, Hanneke W.M. van Laarhoven, Hans Crezee, Aart J. Nederveen, Xiantong Zhen, Oliver J. Gurney-Champion
Publikováno v:
Medical Image Analysis, 80:102512. Elsevier
Ottens, T, Barbieri, S, Orton, M R, Klaassen, R, van Laarhoven, H W M, Crezee, H, Nederveen, A J, Zhen, X & Gurney-Champion, O J 2022, ' Deep learning DCE-MRI parameter estimation : Application in pancreatic cancer ', Medical Image Analysis, vol. 80, 102512 . https://doi.org/10.1016/j.media.2022.102512
Medical image analysis, 80:102512. Elsevier
Ottens, T, Barbieri, S, Orton, M R, Klaassen, R, van Laarhoven, H W M, Crezee, H, Nederveen, A J, Zhen, X & Gurney-Champion, O J 2022, ' Deep learning DCE-MRI parameter estimation : Application in pancreatic cancer ', Medical Image Analysis, vol. 80, 102512 . https://doi.org/10.1016/j.media.2022.102512
Medical image analysis, 80:102512. Elsevier
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is an MRI technique for quantifying perfusion that can be used in clinical applications for classification of tumours and other types of diseases. Conventionally, the non-linear least squ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1694ed2db665003252a1c5ce0d1017f
https://research.vumc.nl/en/publications/260ad64d-c588-4df0-abda-0206fb9abfb7
https://research.vumc.nl/en/publications/260ad64d-c588-4df0-abda-0206fb9abfb7